Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Action of MK‐7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation
David M. Richards, Joel R. Gever, Anthony Ford, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 13, pp. 2279-2291
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
Péter Illés, Christa E. Müller, Kenneth A. Jacobson, et al.
British Journal of Pharmacology (2020) Vol. 178, Iss. 3, pp. 489-514
Open Access | Times Cited: 244
Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
Alyn H. Morice, John A. Smith, Lorcan McGarvey, et al.
European Respiratory Journal (2021) Vol. 58, Iss. 5, pp. 2004240-2004240
Open Access | Times Cited: 79
Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
Stuart B. Mazzone, Lorcan McGarvey
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 3, pp. 619-636
Open Access | Times Cited: 77
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review
Andreas Papapetropoulos, Stavros Topouzis, S P H Alexander, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 11, pp. 1553-1575
Open Access | Times Cited: 11
Ion channels in osteoarthritis: emerging roles and potential targets
Renpeng Zhou, Wenyu Fu, Dmytro V. Vasylyev, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 9, pp. 545-564
Closed Access | Times Cited: 8
Nociceptive signaling mediated by P2X3, P2X4 and P2X7 receptors
Kazuhide Inoue, Makoto Tsuda
Biochemical Pharmacology (2020) Vol. 187, pp. 114309-114309
Open Access | Times Cited: 56
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers
Adam J. Davenport, Ioana Berindan‐Neagoe, Nico Bräuer, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 49
The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
Christian Friedrich, Klaus Francke, Surinder S. Birring, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 22
P2X3-Containing Receptors as Targets for the Treatment of Chronic Pain
Jeffrey L. Krajewski
Neurotherapeutics (2020) Vol. 17, Iss. 3, pp. 826-838
Open Access | Times Cited: 47
Endometriosis and pain in the adolescent- striking early to limit suffering: A narrative review
Christine B. Sieberg, Claire E. Lunde, David Borsook
Neuroscience & Biobehavioral Reviews (2019) Vol. 108, pp. 866-876
Open Access | Times Cited: 46
Nociceptive signaling of P2X receptors in chronic pain states
Kazuhide Inoue
Purinergic Signalling (2020) Vol. 17, Iss. 1, pp. 41-47
Open Access | Times Cited: 41
Gefapixant: First Approval
Anthony Markham
Drugs (2022) Vol. 82, Iss. 6, pp. 691-695
Closed Access | Times Cited: 26
Molecular Pharmacology of P2X Receptors: Exploring Druggable Domains Revealed by Structural Biology
Adam Oken, Ipsita Krishnamurthy, Jonathan C. Savage, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
The Role of ATP Receptors in Pain Signaling
Kazuhide Inoue
Neurochemical Research (2022) Vol. 47, Iss. 9, pp. 2454-2468
Closed Access | Times Cited: 23
Association between P2X3 receptors and neuropathic pain: As a potential therapeutic target for therapy
Cairong Dong, Wenjun Zhang, Hongliang Luo
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113029-113029
Open Access | Times Cited: 23
Role of ATP in migraine mechanisms: focus on P2X3 receptors
Rashid Giniatullin, Andrea Nistri
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications
Gabriella Marucci, Diego Dal Ben, Michela Buccioni, et al.
Expert Opinion on Therapeutic Patents (2019) Vol. 29, Iss. 12, pp. 943-963
Open Access | Times Cited: 37
First‐in‐human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics
Stefan Klein, Isabella Gashaw, Sybille Baumann, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 10, pp. 4552-4564
Open Access | Times Cited: 19
Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough
Shota Yamamoto, Nobuyuki Horita, Johsuke Hara, et al.
CHEST Journal (2024) Vol. 166, Iss. 5, pp. 1124-1140
Closed Access | Times Cited: 4
Efficacy and Safety of varying dosage of Gefapixant in Patients with chronic cough. A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Muhammad Hudaib, Nishat Tabassum, Hurais Malik, et al.
Research Square (Research Square) (2025)
Closed Access
MIDD in Japan– Implementations, challenges and opportunities
Mayumi Hasegawa, Shinichi Kijima
Advanced Drug Delivery Reviews (2025), pp. 115553-115553
Closed Access
Peripheral and central mechanisms of cough hypersensitivity
N. Singh, Alexandria K. Driessen, Alice E. McGovern, et al.
Journal of Thoracic Disease (2020) Vol. 12, Iss. 9, pp. 5179-5193
Open Access | Times Cited: 28
Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study
Christian Friedrich, Klaus Francke, Isabella Gashaw, et al.
Clinical Pharmacokinetics (2022) Vol. 61, Iss. 8, pp. 1143-1156
Open Access | Times Cited: 18
Platelets and the Role of P2X Receptors in Nociception, Pain, Neuronal Toxicity and Thromboinflammation
Elias Rawish, Harald F. Langer
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6585-6585
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top